Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bms 742413
2. Bms-742413
3. N-(3-(7-methyl-1h-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl))-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide
1. Vazegepant
2. Bms-742413
3. Bhv-3500
4. Zavegepant [usan]
5. Odu3zaz94j
6. Bms-742413-01
7. 1337918-83-8
8. Chembl2397415
9. N-[(2r)-3-(7-methyl-1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-1h-quinolin-3-yl)piperidine-1-carboxamide
10. 1-piperidinecarboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-n-((1r)-1-((7-methyl-1h-indazol-5-yl)methyl)-2-(4-(1-methyl-4-piperidinyl)-1-piperazinyl)-2-oxoethyl)-
11. 4-(1,2-dihydro-2-oxo-3-quinolinyl)-n-((1r)-1-((7-methyl-1h-indazol-5-yl)methyl)-2-(4-(1-methyl-4-piperidinyl)-1-piperazinyl)-2-oxoethyl)-1-piperidinecarboxamide
12. Zavegepant [inn]
13. Unii-odu3zaz94j
14. Vazegepant [who-dd]
15. Schembl107428
16. Gtpl11513
17. Ex-a6698
18. Bdbm50436107
19. Bms742413
20. Who 11512
21. Hy-134992
22. Cs-0168642
Molecular Weight | 638.8 g/mol |
---|---|
Molecular Formula | C36H46N8O3 |
XLogP3 | 3.1 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 638.36928736 g/mol |
Monoisotopic Mass | 638.36928736 g/mol |
Topological Polar Surface Area | 117 Ų |
Heavy Atom Count | 47 |
Formal Charge | 0 |
Complexity | 1160 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41470
Submission : 2025-03-11
Status : Active
Type : II
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Jinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Maithri Drugs: Delivering Trusted, High-Quality APIs to 35+ Countries with Innovation, Compliance, and Excellence.
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
99
PharmaCompass offers a list of Zavegepant HCl API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zavegepant HCl manufacturer or Zavegepant HCl supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zavegepant HCl manufacturer or Zavegepant HCl supplier.
PharmaCompass also assists you with knowing the Zavegepant HCl API Price utilized in the formulation of products. Zavegepant HCl API Price is not always fixed or binding as the Zavegepant HCl Price is obtained through a variety of data sources. The Zavegepant HCl Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A BHV-3500 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BHV-3500, including repackagers and relabelers. The FDA regulates BHV-3500 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BHV-3500 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of BHV-3500 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A BHV-3500 supplier is an individual or a company that provides BHV-3500 active pharmaceutical ingredient (API) or BHV-3500 finished formulations upon request. The BHV-3500 suppliers may include BHV-3500 API manufacturers, exporters, distributors and traders.
click here to find a list of BHV-3500 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A BHV-3500 DMF (Drug Master File) is a document detailing the whole manufacturing process of BHV-3500 active pharmaceutical ingredient (API) in detail. Different forms of BHV-3500 DMFs exist exist since differing nations have different regulations, such as BHV-3500 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A BHV-3500 DMF submitted to regulatory agencies in the US is known as a USDMF. BHV-3500 USDMF includes data on BHV-3500's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The BHV-3500 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of BHV-3500 suppliers with USDMF on PharmaCompass.
A BHV-3500 written confirmation (BHV-3500 WC) is an official document issued by a regulatory agency to a BHV-3500 manufacturer, verifying that the manufacturing facility of a BHV-3500 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting BHV-3500 APIs or BHV-3500 finished pharmaceutical products to another nation, regulatory agencies frequently require a BHV-3500 WC (written confirmation) as part of the regulatory process.
click here to find a list of BHV-3500 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing BHV-3500 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for BHV-3500 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture BHV-3500 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain BHV-3500 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a BHV-3500 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of BHV-3500 suppliers with NDC on PharmaCompass.
BHV-3500 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of BHV-3500 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right BHV-3500 GMP manufacturer or BHV-3500 GMP API supplier for your needs.
A BHV-3500 CoA (Certificate of Analysis) is a formal document that attests to BHV-3500's compliance with BHV-3500 specifications and serves as a tool for batch-level quality control.
BHV-3500 CoA mostly includes findings from lab analyses of a specific batch. For each BHV-3500 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
BHV-3500 may be tested according to a variety of international standards, such as European Pharmacopoeia (BHV-3500 EP), BHV-3500 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (BHV-3500 USP).